GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (NSE:SUVENPHAR) » Definitions » 3-Year Book Growth Rate

Suven Pharmaceuticals (NSE:SUVENPHAR) 3-Year Book Growth Rate : 20.20% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals 3-Year Book Growth Rate?

Suven Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 was ₹77.72.

During the past 12 months, Suven Pharmaceuticals's average Book Value per Share Growth Rate was 2.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 20.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was 28.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 6 years, the highest 3-Year average Book Value per Share Growth Rate of Suven Pharmaceuticals was 37.30% per year. The lowest was 20.20% per year. And the median was 27.10% per year.


Competitive Comparison of Suven Pharmaceuticals's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Pharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suven Pharmaceuticals's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Pharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Suven Pharmaceuticals's 3-Year Book Growth Rate falls into.



Suven Pharmaceuticals 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Suven Pharmaceuticals  (NSE:SUVENPHAR) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Suven Pharmaceuticals 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Suven Pharmaceuticals Business Description

Traded in Other Exchanges
Address
No. 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad, TG, IND, 500081
Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.

Suven Pharmaceuticals Headlines

No Headlines